Clinical research progress of stem cell therapy for decompensated cirrhosis and liver failure
10.3760/cma.j.cn501113-20250210-00052
- VernacularTitle:干细胞治疗失代偿肝硬化和肝衰竭的临床研究进展
- Author:
Yanhu WANG
1
;
Yunbo XIE
1
;
Ziying ZHANG
1
;
Yuefei PAN
1
;
Fusheng WANG
1
Author Information
1. 中国人民解放军总医院第五医学中心感染病医学部 国家感染性疾病临床医学研究中心，北京 100039
- Publication Type:Journal Article
- Keywords:
Stem cell;
Cell therapy;
End-stage liver disease;
Liver cirrhosis;
Liver failure
- From:
Chinese Journal of Hepatology
2025;33(2):103-107
- CountryChina
- Language:Chinese
-
Abstract:
Chronic liver disease remains a severe threat to human health. Furthermore, if left untreated promptly and effectively, it may gradually develop into end-stage liver disease, including decompensated cirrhosis and liver failure. Currently, mesenchymal stem cell technology is acting as a kind of an emerging treatment method, and multiple clinical trials have confirmed its promising application prospects in the treatment of decompensated cirrhosis and liver failure. Hence, stem cell therapy may offer a novel therapeutic option for these patients. This article summarizes the clinical research progress of stem cell therapy for decompensated cirrhosis and liver failure and analyzes present challenges and application prospects.
